Manulife’s New Share‑Buyback & Issuer Bid: Why Stakeholders Must Question the Rationale
Manulife’s new equity bid and 42‑million‑share buyback—without clear strategic rationale—raise red flags about shareholder value, governance, and long‑term health.
4 minutes to read









